Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Chemotherapy"
DOI: 10.1080/1120009x.2022.2073160
Abstract: Abstract Ceftolozane/tazobactam (C/T) and ceftazidime/avibactam (CZA) are new possibilities of antimicrobial treatment that combined a β-lactam with a β-lactamase inhibitor. The United States (US) and European regulatory agencies approved their clinical use in adults with…
read more here.
Keywords:
ceftolozane tazobactam;
ceftazidime avibactam;
abdominal infections;
tazobactam ceftazidime ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Systematic Reviews in Pharmacy"
DOI: 10.31838/srp.2020.10.28
Abstract: Background neonatal sepsis is considered as one of the main causes of morbidity and mortality in preterm and full-term neonates. It is a clinical disorder caused by bacterial infections of blood stream. Enterobacteriaceae group (including…
read more here.
Keywords:
sepsis;
study;
ceftazidime;
efficacy combinations ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Antibiotics"
DOI: 10.3390/antibiotics9100640
Abstract: Complicated infections from multidrug-resistant Gram-negative bacteria (MDR-GNB) represent a serious problem presenting many challenges. Resistance to many classes of antibiotics reduces the probability of an adequate empirical treatment, with unfavorable consequences, increasing morbidity and mortality.…
read more here.
Keywords:
ceftazidime avibactam;
ceftolozane tazobactam;
multidrug resistant;
tazobactam ceftazidime ... See more keywords